Fluoroscopy is a medical imaging technique commonly used by physicians or radiologists to obtain real-time moving images of internal structures of the body. Some key advantages of fluoroscopy devices include enabling interventional procedures with precise guidance and dynamic anatomy. The demand for these devices is growing as fluoroscopy allows real-time visualization while performing minimally invasive procedures such as biopsy, catheter placement, and cardiac ablation.

The global Fluoroscopy Devices Market is estimated to be valued at US$ 4720.31 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Opportunity:
The opportunity of increasing demand for minimally invasive procedures is expected to drive the growth of the fluoroscopy devices market over the forecast period. Minimally invasive procedures are gaining popularity as they cause less pain, have lower risk of complications, shorter hospital stay, and faster recovery time compared to open surgeries. Factors such as growing geriatric population suffering from chronic diseases, rising awareness about advantages of minimally invasive treatments, and technological advancements are contributing to the increasing adoption of these procedures. As fluoroscopy devices allow real-time imaging guidance for minimally invasive procedures, their demand is expected to rise significantly with the growth in minimally invasive segment.

Porter's Analysis
Threat of new entrants: The established presence of major players and high capital requirements for R&D and technology pose significant barriers for new companies to enter the market.
Bargaining power of buyers: Individual buyers have low bargaining power due to the specialized nature of devices, while hospitals and large purchasers can negotiate on price and demand additional services.
Bargaining power of suppliers: A few large multinational companies dominate the supply of core system components like tubes, detectors, and robotic devices, giving them significant influence over prices.
Threat of new substitutes: Newer imaging modalities continue to emerge but fluoroscopy remains irreplaceable for many minimally-invasive surgeries due to its advantages in real-time guidance.
Competitive rivalry: Major players compete on product innovations, integrated solutions, service quality, and geographic expansion to gain market share in this consolidating industry.

SWOT Analysis
Strengths: Advanced mobile C-arms and miniaturized equipment have improved accessibility. Integration with software for enhanced visualization and workflow support clinical efficiency.
Weaknesses: High installation and maintenance costs pose financial challenges. Potential radiation risks require careful safety precautions.
Opportunities: Rising chronic disease prevalence is increasing demand for minimally-invasive interventions. Emerging economies offer new markets for penetration. Integration with AI and robotics enables new applications.
Threats: Stringent regulations on approval processes and radiation exposure standards increase compliance burden. Economic slowdowns can negatively impact capital budgets of hospitals.

Key Takeaways

The Global Fluoroscopy Devices Market Demand is expected to witness high growth over the forecast period of 2023 to 2030. The North American region currently dominates the market with the highest share. Rising prevalence of chronic diseases and growing geriatric population are major factors driving demand for minimally invasive treatments utilizing fluoroscopy guidance across various therapeutic areas in the region.

The Asia Pacific region is expected to be the fastest growing market for Fluoroscopy Devices during the forecast period. Rapid economic development, growing healthcare investments, and expansion of private healthcare facilities are fueling market growth in countries like China, India, and South Korea. Increasing medical tourism is also contributing to higher installations of new fluoroscopy systems in Asia Pacific hospitals.

Key players operating in the Fluoroscopy Devices market are Hologic Inc., Siemens Healthcare GmbH, Shimadzu Medical, Koninklijke Philips NV, FUJIFILM Holdings Corporation, Carestream Health, Canon Medical Systems Corporation, General Electric Company (GE Healthcare), and ATON GmbH (Ziehm Imaging Inc. and OrthoScan, Inc.). Major players are focused on developing advanced fully-automated systems with advanced imaging capabilities using novel technologies like AI integrations and miniaturization. Partnerships for geographic expansion and acquisitions for product portfolio enhancement are other key strategies adopted by established brands.

Get more insights on this topic:

https://www.dailyprbulletin.com/fluoroscopy-devices-market-size-market-share-analysis/